Identification and Determination of Impurities in a New Therapeutic Agent for Fatty Liver Disease

Methyl 7,7′-dimethoxy-5′-(morpholinomethyl)-[4,4′-bibenzo[d][1,3] dioxole]-5-carboxylate methanesulfonate (IMM) is an innovative drug for the treatment of nonalcoholic fatty liver disease (NAFLD) owing to its high efficacy and low toxicity. In this study, five minor impurities (I, II, III, IV, and V...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Huihui, Feng, Jing, Zhang, Hanyilan, Zhang, Yuanyuan, Qin, Tong, Hu, Yuhua, Zhang, Wenxuan, Wang, Tiesong, Wu, Song, Yang, Qingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421711/
https://www.ncbi.nlm.nih.gov/pubmed/37575214
http://dx.doi.org/10.1155/2023/3116223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421711/
https://www.ncbi.nlm.nih.gov/pubmed/37575214
http://dx.doi.org/10.1155/2023/3116223

Ejemplares similares